Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Regenerative Medical Technology (RMTG) Depreciation Expense (2019 - 2025)

Historic Depreciation Expense for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to $51693.0.

  • Regenerative Medical Technology's Depreciation Expense fell 1978.49% to $51693.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $57373.0, marking a year-over-year decrease of 7684.36%. This contributed to the annual value of $123020.0 for FY2024, which is 4212.51% down from last year.
  • Latest data reveals that Regenerative Medical Technology reported Depreciation Expense of $51693.0 as of Q3 2025, which was down 1978.49% from $30447.0 recorded in Q2 2025.
  • Regenerative Medical Technology's 5-year Depreciation Expense high stood at $98667.0 for Q3 2023, and its period low was -$52196.0 during Q4 2024.
  • Its 5-year average for Depreciation Expense is $31009.4, with a median of $32243.0 in 2023.
  • Over the last 5 years, Regenerative Medical Technology's Depreciation Expense had its largest YoY gain of 1746250.0% in 2022, and its largest YoY loss of 27365.5% in 2022.
  • Over the past 5 years, Regenerative Medical Technology's Depreciation Expense (Quarter) stood at $26711.0 in 2021, then crashed by 273.66% to -$46385.0 in 2022, then skyrocketed by 256.4% to $72547.0 in 2023, then plummeted by 171.95% to -$52196.0 in 2024, then surged by 199.04% to $51693.0 in 2025.
  • Its Depreciation Expense stands at $51693.0 for Q3 2025, versus $30447.0 for Q2 2025 and $27429.0 for Q1 2025.